fNIRS Studies of Music Intervention of Parkinson's Disease
Therapeutic Benefits of Music for Parkinson's Disease: a fNIRS Study Protocol for Controlled Trial
1 other identifier
interventional
150
1 country
1
Brief Summary
Functional near-infrared spectroscopy (fNIRS) will be used to monitor neuronal activities and connectivity to elucidate the correlation between physiological changes within the brain and the benefits of music therapy for patients afflicted with Parkinson's disease (PD). This study will report on the changes in neural activities as a result of music intervention in PD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable parkinson-disease
Started Jan 2021
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2019
CompletedFirst Posted
Study publicly available on registry
December 30, 2019
CompletedStudy Start
First participant enrolled
January 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedAugust 23, 2021
January 1, 2021
11 months
December 17, 2019
August 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change from Functional Near-infrared Spectroscopy from baseline
An ETG-4000 fNIRS system will be used to measure hemoglobin (HBO2) levels in the participant as they perform finger motor control timing assessments. A change, specifically a reduction of HBO2 activation, from baseline measurements indicates reduced cortical activation and suggests improved PD-related symptoms.
Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)
Change in Synchronous Finger Motor Control Timing Abilities from baseline
Participants will be asked to tap their right index finger on a standard QWERTY keyboard "1" key when a visual cue appears. The response time for tapping the "1" key, in response to seeing the visual cue, will be measured to assess motor-timing control. Accuracy of response will be dependent on minimizing early or delayed taps (measured in milliseconds) in congruence with the determined rhythm. A change in score, particularly greater accuracy in timing, from baseline indicates better or improved motor control performance.
Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)
Change in Continuous Finger Motor Control Timing Abilities from baseline
Participants will be asked to tap their right index finger on a standard QWERTY keyboard "1" key when a visual cue appears. The participants will then be asked to maintain the tapping rhythm without the visual cue for 15 seconds. The timing of tapping the "1" key, without the visual cue, will be measured to assess motor-timing control. Accuracy of response will be dependent on minimizing early or delayed taps (measured in milliseconds) in congruence with the determined rhythm. A change in score, particularly greater accuracy in timing, from baseline indicates better or improved motor control performance.
Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)
Change in Unified Parkinson Disease Rating Scale (UPDRS) from baseline
UPDRS objectively assesses the severity of PD based off the disease's burden on the individual and can describe disease progression and treatment response. A total of 42 ratings are split between multiple categories. Examples of categories measured include mental impairments (mood and intelligence), activities in daily living (speech, salivation, level of independence to perform normal tasks such as turning in bed), motor skills (facial, tremor severity in extremities, rigidity) and other complications. Each category has a 0-4 rating determined by the examiner and summed, where a higher score reflects greater disability (maxed at 195 points). A change in the score, i.e. lower score from baseline, indicates beneficial effects of the intervention.
Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)
Secondary Outcomes (2)
Montreal Cognitive Assessment (MoCA)
Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)
n-Back Working Memory Assessment
Week 0 (baseline), week 4 (during), week 8 (end), and week 12 (follow-up)
Study Arms (2)
Music Therapy
EXPERIMENTALThis group will be asked to practice a rhythmic auditory SFT intervention task at home.
No Music Therapy
NO INTERVENTIONThis group will not engage in an intervention task at home and will be asked to continue their normal daily routine.
Interventions
Participants in the intervention arm will be asked to practice a rhythmic auditory synchronous finger tapping intervention task at home for a total of 25 minutes split between two ten-minute sets with a five-minute break between the sets every day for 8-weeks. During training sessions participants must listen to the instrumental of a pre-selected well-known Chinese melody, "Moonlight over the Lotus Pond" by Phoenix Legend, whose melody duration is 259s. This song was selected for its strong beat and familiarity to the participants. Participants must follow the beats of the melody and tap their right index finger simultaneously to the beats. A visual cue will be displayed to indicate the beats, identical to the one in the assessment. The training session will be conducted once daily after patients have taken their medication. Participants' primary caretaker will be asked to monitor and record completion of sessions.
Eligibility Criteria
You may qualify if:
- Aged 40-80 years old, both genders, and right handed;
- Clinical diagnosis of idiopathic PD according to the 2015 Movement Disorder Society (MDS) Clinical Diagnostic Criteria for Parkinson's Disease;
- Rated as stage I to II on the Hoehn and Yahr scale;
- Scores greater than 21 points on the Montreal Cognitive Assessment (MoCA);
- Maintain a stable dosing of anti-PD or deep-brain stimulation (DBS) treatment throughout the duration of the study;
- Able to travel to and participate in the data collection process.
You may not qualify if:
- Presence of significant hearing or visual impairments;
- Extensive previous musical training;
- A history of any other neurological condition (i.e. Alzheimer's disease, epilepsy, stroke) or psychiatric disorders (i.e. major depression, psychoses).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China
Related Publications (1)
Pu L, Qureshi NK, Ly J, Zhang B, Cong F, Tang WC, Liang Z. Therapeutic benefits of music-based synchronous finger tapping in Parkinson's disease-an fNIRS study protocol for randomized controlled trial in Dalian, China. Trials. 2020 Oct 16;21(1):864. doi: 10.1186/s13063-020-04770-9.
PMID: 33066811DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhanhua Liang, MD
The First Affiliated Hospital of Dalian Medical University
- PRINCIPAL INVESTIGATOR
Bingwei Zhang, MD
The First Affiliated Hospital of Dalian Medical University
- PRINCIPAL INVESTIGATOR
Fengyu Cong, PhD
Dalian University of Technology
- PRINCIPAL INVESTIGATOR
William C Tang, PhD
University of California, Irvine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Patients and the outcomes assessor are blinded in this study
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2019
First Posted
December 30, 2019
Study Start
January 18, 2021
Primary Completion
December 1, 2021
Study Completion
January 1, 2022
Last Updated
August 23, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share